Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer

Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer

Objective. While the value of Ki-67 has been recognized in breast cancer, controversy also exists. The goal of this study is to show the prognostic value of Ki-67 according to progesterone receptor (PgR) expression in patients who have estrogen receptor- (ER-) positive, human epidermal growth factor...

Full description

Bibliographic Details
Main Authors:	Young-Joon Kang, Han-Byoel Lee, Yun Gyoung Kim, JaiHong Han, Yumi Kim, Tae-Kyung Yoo, Eun-Shin Lee, Hyeong-Gon Moon, Dong-Young Noh, Wonshik Han
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Journal of Oncology
Online Access:	http://dx.doi.org/10.1155/2019/7386734

Similar Items

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.
by: Yuqin Ding, et al.
Published: (2020-01-01)

The Correlation between Traditional Ultrasound Features and the Expression of Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor-2, and Ki-67 in Breast Carcinoma
by: Ping Wang, MM, Junfan Li, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM
Published: (2018-12-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
by: Nasrin Shayanfar, et al.
Published: (2010-06-01)

Expression of Progestrone Receptor and Proliferative Marker ki 67, in Various Grades of Meningioma
by: Nasrin Shayanfar, et al.
Published: (2010-05-01)

Folate receptor and Ki-67 nucleoprotein expressions in cervical cancer tissue and their correlation
by: Ran Yan, et al.
Published: (2016-01-01)

Role of co-expression of estrogen receptor beta and Ki67 in prostate adenocarcinoma
by: Nornazirah Azizan, et al.
Published: (2018-07-01)

The expression of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2-neu, p53 and Ki-67 in epithelial ovarian tumors and its correlation with clinicopathologic variables
by: Mary T Sylvia, et al.
Published: (2012-01-01)

Vitamin D Receptor, Retinoid X Receptor, Ki-67, Survivin, and Ezrin Expression in Canine Osteosarcoma
by: John Davies, et al.
Published: (2012-01-01)

Comparison of immunohistochemical characteristics of expression estrogen receptors-alpha, progesterone receptors, p16, p53, Ki-67 and caspase 3 in invasive endometrial adenocarcinoma of different grade.
by: V. A. Tumanskiy, et al.
Published: (2016-09-01)

Associations of Estrogen Receptor, Progesterone Receptor, Human Epidemic Growth Factor Receptor-2 and Ki-67 with Ultrasound Signs and Prognosis of Breast Cancer Patients
by: Zhao X, et al.
Published: (2021-06-01)

Comparative immunohistochemical characteristics of expression of estrogen receptors-alpha, progesterone receptors, p16, p53, Ki-67 and caspase 3 in invasive endometrial adenocarcinoma and normal proliferative endometrium
by: V. A. Tumanskiy, et al.
Published: (2016-04-01)

The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities.
by: Jaihong Han, et al.
Published: (2017-01-01)

Differential expression of estrogen receptor α and progesterone receptor in the normal and cryptorchid testis of a dog
by: Hyo Young Jung, et al.
Published: (2016-12-01)

Immunohistochemical Expression of Ki67 and p53 in Primary Breast Carcinoma and Combined Ki67-p53 Status Phenotypes in Hormone Receptor Positive Breast Carcinoma
by: Rishiraj Baruah, et al.
Published: (2020-03-01)

The Ki-67 immunohistochemical expression of colorectal polyps
by: Aynur Safiyeva, et al.
Published: (2020-05-01)

Estrogen and progesterone receptor expression in breast carcinoma
by: TB Pathak, et al.
Published: (2011-10-01)

Expressions of MVD, VEGF, Ki67 in Residual Prostate Cancer after Cryoablation
by: Yong Li, et al.
Published: (2011-03-01)

Ki-67 expression in anal intraepithelial neoplasia in AIDS
by: Edenilson Eduardo Calore, et al.
Published: (2001-05-01)

Prothymosin-alpha and Ki-67 expression in pituitary adenomas
by: Iga Wierzbicka-Tutka, et al.
Published: (2016-11-01)

Expression and clinicopathological correlation of Ki-67 in gallbladder carcinoma
by: Amit Gupta, et al.
Published: (2021-01-01)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
by: Ming Zeng, et al.
Published: (2021-03-01)

Protein expression and physiological function of Progesterone Receptor Membrane Component 1_Human
by: Szu-Han Chou, et al.
Published: (2011)

Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information
by: Zorka Inic, et al.
Published: (2014-01-01)

Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information
by: Zorka Inic, et al.
Published: (2014-09-01)

The Emotional Status, Attitudes in Decision-Making Process, and Their Impact on Surgical Choices in Korean Breast Cancer Patients
by: Sook Young Jeon, et al.
Published: (2021-01-01)

Expression of estrogen and progesterone receptors in subcutaneous endometriosis
by: Đorđević M., et al.
Published: (2010-01-01)

Expression of p16 and pKi-67 in cervical preneoplasia and neoplasia
by: Looi, Mee-Lee, et al.
Published: (2011)

A Case of a Rapidly Progressive Small Bowel Lymphoma with High Ki-67 Expression
by: Jiyeon Yoo, et al.
Published: (2017-03-01)

Distinct Somatic Alteration Features Identified by Gene Panel Sequencing in Korean Triple-Negative Breast Cancer with High Ki67 Expression
by: Woo Young Sun, et al.
Published: (2021-03-01)

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01)

Correlate study on KI-67 antigen expression in gastric carcinomas
by: Luminita Ivan, et al.
Published: (2009-03-01)

Expressions of Bcl-2, Bax and Ki67 in the primary pterygium
by: Juan Li, et al.
Published: (2018-05-01)

Significance of p53 and ki-67 expression in prostate cancer
by: Renuka Verma, et al.
Published: (2015-01-01)

A cytohistological study of Ki-67 expression in ovarian tumors
by: Monisha Choudhury, et al.
Published: (2011-01-01)

Ki-67 expression as an indicator of invasiveness in patients with breast cancer
by: Ahmed Salah Mahdi, et al.
Published: (2018-01-01)

Ki-67 expression in squamous intraepithelial lesions of the uterine cervix
by: Panjković Milana, et al.
Published: (2006-01-01)

Analysis of the expression of AgNOR, PCNA, and Ki-67 antigen in
by: WU, CHIEH-JEN, et al.
Published: (1996)

Ki-67 Expression is Correlated with Cyst Size and Stage of Endometriosis
by: Muhammad Alif, et al.
Published: (2013-07-01)

Glucose transporter 1 expression in bladder carcinoma and its association with human epidermal growth factor receptor-2 and Ki-67
by: Sheeja Sainulabdeen, et al.
Published: (2019-01-01)

Parallel determination of NeuroD1, Chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers
by: L. Cindolo, et al.
Published: (2011-02-01)